109 related articles for article (PubMed ID: 26100016)
1. p300 Regulates Liver Functions by Controlling p53 and C/EBP Family Proteins through Multiple Signaling Pathways.
Breaux M; Lewis K; Valanejad L; Iakova P; Chen F; Mo Q; Medrano E; Timchenko L; Timchenko N
Mol Cell Biol; 2015 Sep; 35(17):3005-16. PubMed ID: 26100016
[TBL] [Abstract][Full Text] [Related]
2. Age-specific CUGBP1-eIF2 complex increases translation of CCAAT/enhancer-binding protein beta in old liver.
Timchenko LT; Salisbury E; Wang GL; Nguyen H; Albrecht JH; Hershey JW; Timchenko NA
J Biol Chem; 2006 Oct; 281(43):32806-19. PubMed ID: 16931514
[TBL] [Abstract][Full Text] [Related]
3. HDAC1 cooperates with C/EBPalpha in the inhibition of liver proliferation in old mice.
Wang GL; Salisbury E; Shi X; Timchenko L; Medrano EE; Timchenko NA
J Biol Chem; 2008 Sep; 283(38):26169-78. PubMed ID: 18622015
[TBL] [Abstract][Full Text] [Related]
4. RNA CUG-binding protein 1 increases translation of 20-kDa isoform of CCAAT/enhancer-binding protein beta by interacting with the alpha and beta subunits of eukaryotic initiation translation factor 2.
Timchenko NA; Wang GL; Timchenko LT
J Biol Chem; 2005 May; 280(21):20549-57. PubMed ID: 15788409
[TBL] [Abstract][Full Text] [Related]
5. Cooperation of C/EBP family proteins and chromatin remodeling proteins is essential for termination of liver regeneration.
Jin J; Hong IH; Lewis K; Iakova P; Breaux M; Jiang Y; Sullivan E; Jawanmardi N; Timchenko L; Timchenko NA
Hepatology; 2015 Jan; 61(1):315-25. PubMed ID: 25043739
[TBL] [Abstract][Full Text] [Related]
6. HDAC1 promotes liver proliferation in young mice via interactions with C/EBPbeta.
Wang GL; Salisbury E; Shi X; Timchenko L; Medrano EE; Timchenko NA
J Biol Chem; 2008 Sep; 283(38):26179-87. PubMed ID: 18622014
[TBL] [Abstract][Full Text] [Related]
7. Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
Kitagawa M; Lee SH; McCormick F
Mol Cell; 2008 Feb; 29(2):217-31. PubMed ID: 18243116
[TBL] [Abstract][Full Text] [Related]
8. Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments.
Hong IH; Lewis K; Iakova P; Jin J; Sullivan E; Jawanmardi N; Timchenko L; Timchenko N
J Biol Chem; 2014 Jan; 289(2):1106-18. PubMed ID: 24273171
[TBL] [Abstract][Full Text] [Related]
9. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
Lee JH; Kim HS; Lee SJ; Kim KT
J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
[TBL] [Abstract][Full Text] [Related]
10. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
11. The role of CUGBP1 in age-dependent changes of liver functions.
Jones K; Timchenko L; Timchenko NA
Ageing Res Rev; 2012 Sep; 11(4):442-9. PubMed ID: 22446383
[TBL] [Abstract][Full Text] [Related]
12. GSK3beta-cyclin D3-CUGBP1-eIF2 pathway in aging and in myotonic dystrophy.
Jin J; Wang GL; Salisbury E; Timchenko L; Timchenko NA
Cell Cycle; 2009 Aug; 8(15):2356-9. PubMed ID: 19571675
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/enhancer-binding protein α is required for hepatic outgrowth via the p53 pathway in zebrafish.
Yuan H; Wen B; Liu X; Gao C; Yang R; Wang L; Chen S; Chen Z; de The H; Zhou J; Zhu J
Sci Rep; 2015 Oct; 5():15838. PubMed ID: 26511037
[TBL] [Abstract][Full Text] [Related]
14. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
15. Increased GADD gene expression in human colon epithelial cells exposed to deoxycholate.
Scott DW; Mutamba S; Hopkins RG; Loo G
J Cell Physiol; 2005 Jan; 202(1):295-303. PubMed ID: 15316935
[TBL] [Abstract][Full Text] [Related]
16. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V
Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608
[TBL] [Abstract][Full Text] [Related]
17. Binding and modulation of p53 by p300/CBP coactivators.
Lill NL; Grossman SR; Ginsberg D; DeCaprio J; Livingston DM
Nature; 1997 Jun; 387(6635):823-7. PubMed ID: 9194565
[TBL] [Abstract][Full Text] [Related]
18. PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer.
Li Q; Hao Q; Cao W; Li J; Wu K; Elshimali Y; Zhu D; Chen QH; Chen G; Pollack JR; Vadgama J; Wu Y
Sci Adv; 2019 Oct; 5(10):eaaw8417. PubMed ID: 31663018
[TBL] [Abstract][Full Text] [Related]
19. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
[TBL] [Abstract][Full Text] [Related]
20. Chromatin remodelling protein SMAR1 inhibits p53 dependent transactivation by regulating acetyl transferase p300.
Sinha S; Malonia SK; Mittal SP; Mathai J; Pal JK; Chattopadhyay S
Int J Biochem Cell Biol; 2012 Jan; 44(1):46-52. PubMed ID: 22074660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
